Vanguard Group’s Tenon Medical TNON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$111K Hold
3,324
﹤0.01% 4163
2025
Q3
$137K Buy
+3,324
New +$141K ﹤0.01% 4183
2024
Q3
Sell
-85
Closed -$14.6K 4383
2024
Q2
$14.6K Hold
85
﹤0.01% 4376
2024
Q1
$22.7K Hold
85
﹤0.01% 4383
2023
Q4
$37.7K Buy
+85
New +$41.6K ﹤0.01% 4391
2023
Q2
Sell
-14
Closed -$67.3K 4570
2023
Q1
$67.3K Sell
14
-19
-58% -$105K ﹤0.01% 4441
2022
Q4
$148K Buy
33
+7
+27% +$35.7K ﹤0.01% 4348
2022
Q3
$96K Buy
26
+18
+225% +$105K ﹤0.01% 4500
2022
Q2
$51K Buy
+8
New +$233K ﹤0.01% 4584

Other funds holding TNON

Vanguard Group's TNON Position: Q4 2025 in Review

Vanguard Group held its Tenon Medical (TNON) position steady in Q4 2025 at 3,324 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #4163.

Vanguard Group first reported a position in TNON in Q2 2022 and has held it in 9 quarters since. The position peaked at $148K in Q4 2022. 16 funds tracked by Wall St. Rank hold TNON as of Q4 2025.

  • Vanguard Group held 3,324 shares of Tenon Medical worth $111K as of Q4 2025.
  • Vanguard Group left its Tenon Medical share count unchanged in Q4 2025.
  • Tenon Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4163 holding.
  • Vanguard Group first reported a position in Tenon Medical in Q2 2022 and has held it in 9 quarters since.
  • Vanguard Group's Tenon Medical position peaked at $148K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Tenon Medical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.